Page last updated: 2024-09-04

centchroman and Adenocarcinoma

centchroman has been researched along with Adenocarcinoma in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Behrman, SW; Chauhan, N; Chauhan, SC; Ebeling, MC; Ganju, A; Gara, RK; Jaggi, M; Khan, S; Singh, MM; Thompson, PA; Yallapu, MM; Zafar, N; Zhao, H	1
Balapure, AK; Kaushik, S; Sharma, R; Shyam, H; Singh, N	1

Other Studies

2 other study(ies) available for centchroman and Adenocarcinoma

Article	Year
Ormeloxifene suppresses desmoplasia and enhances sensitivity of gemcitabine in pancreatic cancer. Cancer research, 2015, Jun-01, Volume: 75, Issue:11 Topics: Adenocarcinoma; Animals; Apoptosis; Benzopyrans; Cell Line, Tumor; Cell Proliferation; Deoxycytidine; Drug Resistance, Neoplasm; Drug Synergism; Gemcitabine; Humans; Mice; Pancreatic Neoplasms; Xenograft Model Antitumor Assays	2015
Centchroman induces redox-dependent apoptosis and cell-cycle arrest in human endometrial cancer cells. Apoptosis : an international journal on programmed cell death, 2017, Volume: 22, Issue:4 Topics: Adenocarcinoma; Antineoplastic Agents, Hormonal; Apoptosis; Caspases; Cell Cycle Checkpoints; Cell Cycle Proteins; Cell Line, Tumor; Centchroman; Cyclin D1; Cyclin E; DNA Fragmentation; Endometrial Neoplasms; Female; Humans; Inhibitory Concentration 50; MAP Kinase Signaling System; Membrane Potential, Mitochondrial; Neoplasm Proteins; Oxidation-Reduction; Protein Transport	2017

Article

Year

Ormeloxifene suppresses desmoplasia and enhances sensitivity of gemcitabine in pancreatic cancer.

Cancer research, 2015, Jun-01, Volume: 75, Issue:11

Topics: Adenocarcinoma; Animals; Apoptosis; Benzopyrans; Cell Line, Tumor; Cell Proliferation; Deoxycytidine; Drug Resistance, Neoplasm; Drug Synergism; Gemcitabine; Humans; Mice; Pancreatic Neoplasms; Xenograft Model Antitumor Assays

2015

Centchroman induces redox-dependent apoptosis and cell-cycle arrest in human endometrial cancer cells.

Apoptosis : an international journal on programmed cell death, 2017, Volume: 22, Issue:4

Topics: Adenocarcinoma; Antineoplastic Agents, Hormonal; Apoptosis; Caspases; Cell Cycle Checkpoints; Cell Cycle Proteins; Cell Line, Tumor; Centchroman; Cyclin D1; Cyclin E; DNA Fragmentation; Endometrial Neoplasms; Female; Humans; Inhibitory Concentration 50; MAP Kinase Signaling System; Membrane Potential, Mitochondrial; Neoplasm Proteins; Oxidation-Reduction; Protein Transport

2017